Literature DB >> 215358

Polymorphism of apolipoprotein E. I. Methodological aspects and diagnosis of hyperlipoproteinemia type III without ultracentrifugation.

G Utermann, G Albrecht, A Steinmetz.   

Abstract

Two methods for phenotyping apolipoprotein E are compared. One is based on preparation of VLDL by conventional ultracentrifugation, whereas the other uses heparin/Mg precipitation of VLDG. In principle, the same results were obtained by both methods. However, the group limits for the three different phenotypes Apo E-N, Apo E-ND and Apo E-D were slightly different by the two methods. Phenotype Apo E-D - the phenotype characterizing type III dyslipoproteinemia - is clearly definable by both methods. Hence the precipitation-I.E.F. method for Apo E phenotyping provides a simple tool for genetic and population genetic studies and also for the routine diagnosis of hyperlipoproteinemia type III, based on the only specific marker known for this disease.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 215358

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  4 in total

1.  [Apolipoproteinopathies].

Authors:  G Assmann
Journal:  Klin Wochenschr       Date:  1983-02-15

2.  Genetic control of human apolipoprotein E polymorphism: comparison of one- and two-dimensional techniques of isoprotein analysis.

Authors:  G Utermann; A Steinmetz; W Weber
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

3.  Genetic studies of human apolipoproteins. X. The effect of the apolipoprotein E polymorphism on quantitative levels of lipoproteins in Nigerian blacks.

Authors:  B Sepehrnia; M I Kamboh; L L Adams-Campbell; C H Bunker; M Nwankwo; P P Majumder; R E Ferrell
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

4.  Genetics of the apolipoprotein E system in man.

Authors:  G Utermann; U Langenbeck; U Beisiegel; W Weber
Journal:  Am J Hum Genet       Date:  1980-05       Impact factor: 11.025

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.